Pregnancy, lactation and early childhood are life stages when the risk of low vitamin D status is high and the knowledge basis for determining nutritional requirements for vitamin D is weak. The current dietary reference intervals (DRI) for vitamin D in pregnant and lactating women are the same as those in non-pregnant adult females below 70 years (600 IU/15 mg/d) (1) . The aim of the current study was to investigate vitamin D requirements during lactation. We conducted a double-blind randomised placebo-controlled trial across three intervention groups using 20 mg/d of vitamin D 3 (to achieve a total vitamin D intake of 25 mg/d), with or without 500 mg Ca, or placebo, over 12 weeks of lactation. The study protocol was implemented across a calendar year to account for seasonal effects.
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Concentrations of serum 25-hydroxyvitamin D (s25(OH)D) were measured at baseline (BL) and endpoint (EP) in mothers and in umbilical cord blood using ELISA. Vitamin D metabolites (D 3 , D 2 and 25(OH)D) were quantified in expressed breast milk at four time points during the intervention study using HPLC. Dietary intakes of vitamin D and Ca, anthropometric data, socio-demographic and lifestyle data were collected, as well as antenatal supplement use and habitual sunshine exposure. The s25(OH)D data are described here.
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Total (n 100) Placebo (n 27) Vitamin D (n 36) D and Ca (n 37) P At BL, 21 and 63 % had a s25(OH)D level below the thresholds for vitamin D deficiency and sufficiency of 30 and 50 nmol/l, respectively. Season of blood sampling was the main determinant of BL s25(OH)D (adj. R 2 = 0.338; b = 0.571; P < 0.001), as expected. Other determinants were parity and total vitamin D intake (b = 0.157 and 0.150, respectively; P < 0.05). Mean (SD) cord s25(OH)D levels were 33.8 (14.8) nmol/l (n 92) and were 78 % of maternal levels on average (R 2 = 0.7; P < 0.001). Season of birth (adj. R 2 = 0.274; b = 0.137) and antenatal vitamin D supplement use (adj. R 2 = 0.004; b = 0.140) were independent predictors of cord s25(OH)D levels (both P < 0.05). A final sample of 100 women completed the intervention protocol, of which ninety were more than 80 % compliant. The intervention considerably increased s25(OH)D levels in the treatment groups by 30 nmol/l (see Table) with no difference in the EP concentrations between women who received vitamin D only and those who received vitamin D + Ca. Given that the average habitual vitamin D intake in the group was 4.3 mg/d, supplementation with 20 mg/d vitamin D 3 to achieve a total intake of 25 mg/d, maintained s25(OH)D levels > 30 nmol/l in all lactating women and brought 96 % above the desirable threshold of 50 nmol/l.
In conclusion, the current DRI of 15 mg/d is inadequate to achieve a target s25(OH)D of 50 nmol/l in 97.5 % of lactating women at a latitude of 51 N. Proceedings of the Nutrition Society (2011), 70 (OCE3), E96 doi:10.1017/S0029665111001364
